eFFECTOR Therapeutics (EFTR) Revenue & Revenue Breakdown


OverviewForecastOwnershipFinancialsChart

eFFECTOR Therapeutics Revenue Highlights


00

Main Segment (Y)

Grant Revenue

Main Geography (Y)

Grant Revenue

eFFECTOR Therapeutics Revenue by Period


eFFECTOR Therapeutics Revenue by Year

DateRevenueChange
2023-12-31--100.00%
2022-12-31$3.55M148.46%
2021-12-31$1.43M-96.60%
2020-12-31$42.00M100.00%
2019-12-31--

eFFECTOR Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

eFFECTOR Therapeutics Revenue by Quarter

DateRevenueChange
2024-03-31--100.00%
2023-12-31$162.00K100.00%
2023-09-30-100.00%
2023-06-30-100.00%
2023-03-31--100.00%
2022-12-31$675.00K-22.15%
2022-09-30$867.00K-56.89%
2022-06-30$2.01M100.00%
2022-03-31--100.00%
2021-12-31$1.43M234.89%
2021-09-30$427.00K100.00%
2021-06-30-100.00%
2021-03-31--100.00%
2020-12-31$42.00K-92.68%
2020-09-30$574.00K-

eFFECTOR Therapeutics generated - in revenue during Q1 2024, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.

eFFECTOR Therapeutics Revenue Breakdown


eFFECTOR Therapeutics Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 21
Grant Revenue$1.43M
Collaboration Revenue-

eFFECTOR Therapeutics's latest annual revenue breakdown by segment (product or service), as of Dec 21: Grant Revenue (100.00%).

Quarterly Revenue by Product

Product/ServiceJun 22Dec 21Sep 21
D A R P A Grant$2.00M--
Grant Revenue-$311.00K$427.00K
Collaboration Revenue---

eFFECTOR Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Jun 22: D A R P A Grant (100.00%).

eFFECTOR Therapeutics Revenue Breakdown by Country

Annual Revenue by Country

CountryDec 21
Collaboration Revenue-
Grant Revenue$1.43M

eFFECTOR Therapeutics's latest annual revenue breakdown by geography, as of Dec 21: Grant Revenue (100.00%).

Quarterly Revenue by Country

CountryJun 22Dec 21Sep 21
D A R P A Grant$2.00M--
Grant Revenue-$311.00K$427.00K
Collaboration Revenue---

eFFECTOR Therapeutics's latest quarterly revenue breakdown by geography, as of Jun 22: D A R P A Grant (100.00%).

eFFECTOR Therapeutics Peer Comparison by Revenue


TickerCompanyLast Year RevenueLast Quarter Revenue
ENSCEnsysce Biosciences$2.23M-
RNXTRenovoRx--
VRPXVirpax Pharmaceuticals--
INDPIndaptus Therapeutics--
EFTReFFECTOR Therapeutics--
JSPRJasper Therapeutics--

EFTR Revenue FAQ


eFFECTOR Therapeutics's yearly revenue for 2023 was $0, representing a decrease of -100.00% compared to 2022. The company's yearly revenue for 2022 was $3.55M, representing an increase of 148.46% compared to 2021. EFTR's yearly revenue for 2021 was $1.43M, representing a decrease of -96.60% compared to 2020.

eFFECTOR Therapeutics's quarterly revenue for Q1 2024 was $0, a -100.00% decrease from the previous quarter (Q4 2023), and a 0% increase year-over-year (Q1 2023). The company's quarterly revenue for Q4 2023 was $162K, a 100.00% increase from the previous quarter (Q3 2023), and a -76.00% decrease year-over-year (Q4 2022). EFTR's quarterly revenue for Q3 2023 was $0, a 100.00% increase from the previous quarter (Q2 2023), and a -100.00% decrease year-over-year (Q3 2022).

eFFECTOR Therapeutics's revenue growth rate for the last 3 years (2021-2023) was -100.00%, and for the last 5 years (2019-2023) was 0%.

eFFECTOR Therapeutics's revenue streams in c 21 are Grant Revenue

For the fiscal year ending Dec 21, the largest source of revenue of eFFECTOR Therapeutics was Grant Revenue. This segment made a revenue of $1.43M, representing 100.00% of the company's total revenue.